Navigation Links
InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Date:2/17/2010

BRISBANE, Calif., Feb. 17 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the fourth quarter and 12 months ended December 31, 2009.  InterMune also highlighted its recent clinical development and business activities, and previewed upcoming milestones in 2010.  

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "Fourth quarter and recent events have been highlighted by the very important developments related to the regulatory progress of pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis, or IPF.  Our New Drug Application (NDA) for pirfenidone was granted Priority Review status on January 4, and is scheduled to be discussed at an FDA advisory committee meeting on March 9, 2010.  If approved by the FDA, pirfenidone would be the first approved medicine for the approximately 100,000 Americans who suffer from this terrible disease.  Regarding Europe, we currently expect to submit a Marketing Authorization Application (MAA) for pirfenidone in the European Union in the current quarter."  

Mr. Welch continued, "We were pleased to report in January promising top-line results of the multiple-ascending-dose study of ritonavir-boosted RG7227 (ITMN-191) with standard of care, and look forward to providing further data on RG7227 during the year."

Clinical Development, Business Highlights and Upcoming Milestones

Pirfenidone:  

  • On January 4, we announced the NDA for pirfenidone had been ac
    '/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mike Rowe , spokesperson and reality television personality, will ... 2015 ThoughtSpot conference and tradeshow, which runs from ... Nev. Best known for his ... Channel,s, "Dirty Jobs," Mr. Rowe spent a decade traveling across ... whose hard work, sacrifice and value aren,t always recognized. Prior ...
(Date:7/28/2015)... 2015 Baebies, Inc. today announced the completion ... The oversubscribed round of financing included key investors Rex ... Cunning Capital, Triad, LLC, the Duke Angel Network and ... of Advanced Liquid Logic,s (ALL) former investors including Charleston ... "Rex is pleased to support this promising ...
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
(Date:7/28/2015)... ... 2015 , ... According to WFTV on July 15th heroin overdose ... toxicity cases. According to recent statistic Orlando suffers at least one death weekly as ... of heroin, and law enforcement officials are struggling to keep apace with its distribution. ...
(Date:7/28/2015)... ... July 28, 2015 , ... Brookstone®, a ... System to its online product offerings, giving its customers the opportunity to ... cloud-based technology, SmileCareClub allows patients to get quality, remote invisible aligner treatment from ...
(Date:7/28/2015)... Raleigh, NC (PRWEB) , ... July 28, 2015 ... ... others cancers are more common in shipbreaking workers than they are in the ... Click here to read it now. , Researchers at Taiwan’s National ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa Hasty of ... by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been ... and peers in the metro area as one of the most respected doctors in ...
(Date:7/28/2015)... ... 28, 2015 , ... A June 3, 2015 article ... Injury" discussed baseball player David Wright’s spinal stenosis injury and his chances of ... by degenerative changes in the spine, rather than congenital, which is good news ...
Breaking Medicine News(10 mins):Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3
... ... "CSPA has not had an opportunity for a detailed review ... cannot,make any definitive comment on this specific study, we can ... correlation of,various data. This process does not necessarily demonstrate a ...
... Pa., Oct. 12 Helping its,employees to live a ... Recently, the American Heart Association (AHA) recognized,SAE for those ... Friendly Company, an honor,presented to only a handful of ... What does it mean? In short, it means that ...
... Parametric Release(TM) Instrument Processor, TUCSON, Ariz., Oct. ... of The Manzi Mach 1 Cleaner-Processor, the only,Parametric ... a,fully integrated cleaning, sterilizing and rinsing system that ... This system is designed for,use by hospitals, medical ...
... October 12, 2007 -- Excerpta Medica, an Elsevier ... six decades, has merged with corporate sibling Elsevier ... agency with more than a decades experience creating ... brands. Excerpta Medica will now be able ...
... GNC -- along with thousands of,herb-loving individuals, ... National Herb Day 2007 tomorrow, Oct. 13. The ... of October by giving,customers free 28-ct Mega Men(R) ... or more on herbs. National Herb Day ...
... only real-time PCR test for HIV, INDIANAPOLIS, Oct. ... its 1,700 hospital members access in,August to the Roche ... test for HIV offered to its members. Premier ... and COBAS(R) TaqMan(R) Analyzer to its existing three-year,molecular contract ...
Cached Medicine News:Health News:Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma 2Health News:FDA Grants Clearance to Langford IC Systems, Inc. 2Health News:FDA Grants Clearance to Langford IC Systems, Inc. 3Health News:GNC Honors Herb Day Tomorrow (and All Month Long) 2Health News:Nation's Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract 2Health News:Nation's Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: